Interstrand crosslinks (ICLs) present a major threat to genome integrity, preventing both the correct transcription of active chromatin and complete replication of the genome. This is exploited in genotoxic chemotherapy where ICL induction is used to kill highly proliferative cancer cells.
Introduction
Interstrand crosslinks (ICLs) occur between strands of the duplex DNA, preventing strand separation and thus blocking both transcription and replication of the genome. Repair of ICLs is critical to cell and organismal survival and is conducted in part by the Fanconi anemia (FA) repair pathway, which is thought to coordinate the removal and repair of covalent linkage between two DNA strands [1] [2] [3] . FA-mediated ICL repair is regulated by the S-phase checkpoint protein, ATR kinase, which phosphorylates FANCI, allowing the FA complex to monoubiquitinate FANCD2 [4, 5] .
Though originally thought to promote recruitment of the FANC complex to chromatin bearing a crosslink, and subsequent repair of that crosslink, monoubiquitination of FANCD2 has now been shown to occur after initial DNA recruitment [6] . Repair is thought to involve two incision events and a translesion synthesis event followed by nucleotide excision repair to remove the ICL [7] . The remaining double strand break is then repaired by homologous recombination, which requires 3' overhang substrates and therefore is likely to involve an exonuclease acting on the opposite strand. The 5'-3' nuclease FAN1 was identified in an RNAi screen for factors required for ICL repair following mitomycin C treatment of mammalian cells [8] . FAN1 localises to sites of crosslink damage in a manner dependent on the N-terminal UBZ domain interaction with ubiquitinated FANCD [8] [9] [10] . It has a C-terminal nuclease domain with both structure-specific endonuclease activity (that cleaves nicked and branched structures), and 5'-3' exonuclease activity which could act in crosslink repair, although it does not appear to be involved in the trimming of DNA to allow homologous recombination [8, [10] [11] [12] . The same screen suggested that EXD2, a 3'-5' nuclease, may also be required for the response to mitomycin C, probably acting either downstream of, or in parallel to, FAN1 [8] .
EXD2 has sequence similarity to the 3'-5' exonuclease domain of human WRN ( Figure 1A , also [13] ), a protein with both RecQ-family helicase and DnaQ-like exonuclease domains [14] [15] [16] .
Human EXD2 is predicted to exist as multiple splice variants [17] giving rise to at least two protein isoforms, with the short form predicted to lack the putative 3'-5' exonuclease domain ( Figure 1A ).
Here, we have chosen to investigate the role of EXD2 in Drosophila, in which the EXD2 orthologue is encoded by the gene CG6744, which produces two transcripts, CG6744-RA (1947 bp) and CG6744-RB (1850 bp) and a single predicted polypeptide of 583 amino acids. This orthologue is highly similar to human EXD2, with 40% amino acid identity and 59% similarity ( Figure 1 ) and is referred to here as DmEXD2; it also shares significant homology with human WRN, particularly within the exonuclease domain, where key acidic residues required for nuclease activity in both human and Drosophila WRN are conserved in EXD2 (boxed in Figure 1A ). We have previously demonstrated that DmWRNexo is indeed a bona fide 3'-5' exonuclease [18] , with substrate specificity highly related to that of human WRN exonuclease [18] [19] [20] .
In humans, loss of WRN function leads to the adult onset progeria Werner syndrome (WS) [21] . It is highly probable that genomic instability defects resulting from loss of WRN lead to premature cell senescence and are likely to underlie the early onset of characteristic ageing phenotypes in WS patients, including greying hair, skin changes, type II diabetes mellitus, osteoporosis, lipodystrophy and increased risk of cancer and cardiovascular disease (reviewed in [22] [23] [24] ). Genomic instability arises as a consequence of WRN's critical roles in many aspects of DNA metabolism including telomere processing [25, 26] and DNA repair (e.g. [27] ). Furthermore, WRN preferentially binds to DNA containing Holliday junction and/or replication fork structures [28] [29] [30] [31] , and is present at replication foci coincident with RPA and PCNA [32, 33] . Cells derived from WS patients are highly sensitive to agents such as camptothecin that cause replication fork arrest or collapse, further implicating WRN in DNA replication [34] [35] [36] . Loss or mutation of WRN results in aberrant DNA replication [37] [38] [39] and hyper-recombination [40] [41] [42] [43] [44] . WRN associates with RAD54 family recombination proteins on treatment of cells with mitomycin C (MMC) [45] , and WRN helicase inhibition potentiates toxicity in cells lacking a functional FA pathway [46] . Intriguingly, both the replication and recombination defects can be corrected by ectopic expression of the RusA Holliday junction nuclease [43, 47] , suggesting that it is the nuclease activity of WRN that is important in these processes within the nucleus.
Analysis of the role(s) of both EXD2 and WRN nucleases in ICL repair is important in furthering our understanding of aspects of the ICL pathway downstream of, or in parallel to, the FA complex.
Here, we investigate possible roles of DmEXD2 and DmWRNexo in interstrand crosslink repair. We find that flies mutant for DmEXD2 have elevated rates of genomic instability probably resulting from chromosome breakage, in contrast to DmWRNexo mutants where excess homologous recombination is the principal mechanism of instability. Most notably, we demonstrate that flies mutant for either DmWRNexo or DmEXD2 are deficient in repair of DNA crosslinks caused by diepoxybutane (DEB) and mitomycin C (MMC), strongly suggesting that each nuclease individually plays a role in ICL repair. These findings extend our understanding of ICL repair and we propose that they highlight a novel route to enhancing ICL-dependent cancer chemotherapy. were mated en masse and their progeny propagated on Instant Drosophila Medium (Sigma)
Materials and Methods

Drosophila Stocks and Maintenance
DmWRNexo
supplemented with 0-500 µM diepoxybutane (DEB). Four independent replicate matings were conducted. Sensitivity to DEB was assessed as a deviation from the expected homozygote:
heterozygote ratio in the progeny, and numbers of both male and female heterozygotes and homozygous mutants were determined. The binomial exact test for goodness-of-fit was used to ascertain statistical significance where the fly numbers were fewer than 1000, and when more than 1000, the standard chi-square test of goodness-of-fit was employed.
Isolation and drug treatment of proliferating larval brain cells
Ventral ganglia from third instar larvae of Oregon-R (wild type) and larvae homozygous for mus308
D2
, DmWRNexo e04496 and DmEXD2 c0587 were dissected in 0.7% saline. Tissues were transferred to HyClone SFX-Insect Culture Media (2 ventral ganglia per 100 µl) and treated with 20 µM DEB or 10 µM MMC (in culture medium) for 30 minutes during a total 4.5 hr incubation (see Figure 5A for the experimental scheme). Following treatment, tissues were collected by centrifugation, triturated into single cells and suspended in 100 µl of drug-free culture medium. 
Inverse Comet Assay for ICL Repair
Results
Genome instability in DmWRNexo and DmEXD2 mutants arises through distinct mechanisms
We have previously demonstrated a requirement for DmWRNexo in maintaining genome stability in flies [49] . Given the strong similarities between DmWRNexo and DmEXD2, and the known roles of human WRN [43, 50] and EXD2 [51] in homologous recombination, we first set out to establish the degree and type of genomic instability consequent upon reduction in levels of DmEXD2. We are very rare in these mutants ( Figure 2C ), strongly suggesting that the principal mechanism of genomic instability is chromosome breakage with subsequent loss of the acentric fragments. This contrasts with our finding in flies mutant for DmWRNexo, where the principal mechanism of genomic instability is excessive homologous recombination [49] , and strongly suggests that the two related nucleases act in different molecular pathways.
DmWRNexo and DmEXD2 mutant flies are sensitive to the ICL inducer diepoxybutane
Given the difference in the mechanism of genomic instability consequent on WRNexo or EXD2 loss, we wished to further explore their roles in maintaining genomic integrity. We have previously demonstrated that flies hypomorphic for WRNexo are hypersensitive to the topoisomerase I inhibitor camptothecin [49] , consistent with a requirement for WRN exonuclease during normal or perturbed DNA replication [38, 39, 47] . Human WRN helicase has also been suggested to act in DNA interstrand crosslink repair [52] , supported by studies involving inhibition of WRN helicase [46] . To date, however, no study has directly assessed a possible role of WRN exonuclease in ICL repair because of the difficulty in isolating the nuclease from the helicase activity -dominant negative mutation in one activity is likely to impact on the other. Since flies encode the WRN exonuclease on a genetic locus discrete from the putative WRN helicase [49] , we were able to assess the role of WRN exonuclease in ICL repair, and compare it with the related nuclease EXD2.
We tested the sensitivity of flies mutant for either DmWRNexo or DmEXD2 to the crosslinking agent diepoxybutane (DEB), administered in the diet at concentrations much lower than previously shown to highlight defects in DNA repair pathways [53] . The ratio of homozygotes to heterozygotes in the progeny was assessed for each DEB concentration (0-0. at a DEB concentration of 0.2 mM or higher; note that this is ten-fold lower than the dose to which mus201 and mei-41 mutant flies are reported to be sensitive [53] . Supplementary table S1 catalogues the number of flies eclosing for each genotype at each concentration of DEB, together with the probability that the ratio of homozygotes to heterozygotes differs significantly from the predicted value of 1:2 (i.e. ratio of 0.5 in Figure 3 and Table S1 ). These results confirm that both DmWRNexo and DmEXD2 are required for resistance to DNA crosslinking agents such as DEB, suggesting a role in ICL repair. We find no sex differences in sensitivity of either DmWRNexo or DmEXD2 mutants to DEB ( Figure 3B and 3C respectively). The hypersensitivity of DmWRNexo e04496 mutants (strongly hypomorphic for the WRN exonuclease) to a crosslink inducer is an intriguing finding as it suggests an important role for WRN's exonuclease activity in ICL repair, in addition to the previously suggested ICL repair role of the helicase domain [46, 52] . The DEB sensitivity of DmEXD2 mutants is particularly intriguing, as it provides the first in vivo confirmation of previous in vitro suggestions that implicate EXD2 in ICL repair [8] .
Defective ICL repair contributes to DEB sensitivity in DmWRNexo and DmEXD2 mutant flies.
To confirm that DEB sensitivity was due to defects in ICL repair, persistence of ICLs following recovery from acute DEB exposure was assessed by an inverse comet assay, which measures the ability of cells to recover from drug-induced ICL damage. In this assay, ICLs were induced by treatment with DEB, then following various recovery periods, nuclei were embedded in low Notably, we find that larval neuroblasts from hypomorphic DmWRNexo mutants (i.e. DmWRNexo e04496 ) showed defects in ICL repair ( Figure 5B) ; the lack of repair was highly significant and equivalent to that seen in the positive control DNA polymerase theta mutant, mus308 D2 ( Figure 5D ), which has been reported to be required in ICL repair [54] . We observed no significant increase in comet tail moment over the recovery time periods following DEB treatment, confirming the absence of ICL repair in the mus308 D2 mutant neuroblasts ( Figure 5D ). Moreover, larval neuroblasts derived from DmEXD2 c05871 homozygotes also showed a defect in ICL repair; though a slight increase in comet tail moment was detected at the 1-hour recovery time point, no further increase was observed with longer recovery periods, even after 4 hours following removal of DEB ( Figure 5C Table S2 ). The Wilcoxon Signed Ranks test was used to test significance of recovery patterns over time relative to the 0-hour time point for each strain (Supplementary Figure S2 ). Together these data show that both DmWRNexo and DmEXD2 are required for efficient ICL repair, at least in the highly proliferating cells in larval fly brains.
Both DmWRNexo and DmEXD2 are required for efficient repair of ICLs induced by mitomycin C
Since crosslink-induced structural distortion influences the recruitment of specific protein components from different DNA repair pathways (reviewed in [55] ), the inverse comet assay was repeated with the ICL inducer mitomycin C (MMC), which produces structural distortions that are different from those produced by DEB. An experimental approach identical to that of DEB was adopted, exposing larval neuroblasts to MMC for 30 minutes with variable recovery periods (see schematic Figure 5A ). As with cells treated with DEB, MMC treatment led to decreased comet tail moments as a consequence of formation of interstrand crosslinks. In the wild type Oregon R neuroblasts, significant and sustained increase in mean comet tail moment was observed with increasing recovery time following 30-minute exposure to MMC (Figure 6 , all panels), indicating repair of the cross-links. In contrast, neuroblasts obtained from larvae mutant for either DmWRNexo ( Figure 6A ) or DmEXD2 ( Figure 6B ) showed impaired recovery from MMC-induced ICL damage, to a similar degree as neuroblasts mutant for mus308 D2 ( Figure 6C ), known to be defective in ICL repair. Pair-wise comparisons of mean comet tails moment show highly significant differences between the wild type Oregon-R strain and all mutant strains tested (Supplementary Table S3 ). Taken together, our data demonstrate that ICL repair is defective in fly larvae mutant for either DmWRNexo or DmEXD2, irrespective of the ICL-inducing agent used.
Discussion
Investigations into interstrand crosslink repair generally focus on the complex and still poorly understood Fanconi anemia pathway. However, steps parallel to, or downstream of, FA complex intervention are also critically important not only in understanding how ICL repair is mediated in cells, but also in informing on design of pharmacological modulation, either to promote or, perhaps more excitingly, to inhibit the repair of ICLs in synthetic lethality treatments for cancer using ICL-inducing therapies. Such synthetic lethality therapies, first suggested in 1997 [56] , have shown great promise in breast cancer where BRCA-mutant cells treated with PARP inhibitors are exquisitely sensitive to agents inducing double strand breaks (reviewed in [57] ).
The progeroid WRN helicase/exonuclease has been implicated in ICL repair following observations of sensitivity of patient-derived cells to ICL-inducing agents (e.g. [58] ). Additional nucleases, particularly FAN1 and EXD2 have been proposed to act during ICL repair, but such conclusions are based on in vitro data using either purified proteins and DNA substrates [55] or RNAi screens in cultured cells [8] . Here, we have examined ICL repair in a whole organism, demonstrating requirement for both WRN and EXD2 nucleases in the ICL repair pathway. Drosophila provides significant advantages over cell culture models: firstly, genetic markers allow us to determine not only the degree of genomic instability resulting from loss of function of these nucleases, but also the type of chromosomal damage caused. Secondly, invertebrates encode the functionalities of WRN helicase and exonuclease on separate genetic loci [59] allowing a genetic dissection of their respective roles without the hindrance of dominant negative mutation effects seen in human WS cells.
Our results presented here using genetic markers as readouts of chromosomal instability phenotypes not only confirm our earlier findings of spontaneous genomic instability on hypomorphic mutation of either DmWRNexo [49] or DmEXD2 [13] of genomic instability between flies mutant for DmWRNexo [49] and DmEXD2 (data presented in this paper), suggests that the two highly related enzymes function in distinct molecular pathways and possibly in temporally distinct phases of the cell cycle, though we cannot yet rule out the possibility of partial redundancy.
To date, studies on WRN's involvement in ICL repair have focussed on its helicase activity: FANCD2 knockout cells become more sensitive to MMC when treated with a small molecule inhibitor of WRN helicase (NSC 617145), while exposure to NSC 617145 and MMC led to elevated levels of Rad51 foci [46] suggesting that WRN helicase is required for later steps of HR at ICL-induced DSBs [45] . However, it has been so far unclear if WRN exonuclease plays any part in ICL repair. We addressed this using the Drosophila DmWRNexo e04496 mutant, as this is severely hypomorphic for DmWRNexo [49] , but has intact helicase activity (we find synthetic lethality when both the DmWRNexo and the putative helicase encoded by mus309 are mutated -data not shown). We also utilised flies hypomorphic for DmEXD2, which is highly related to WRN, to assess EXD2 involvement in ICL repair.
It has been proposed that the Fanconi anemia (FA) pathway is the preferred pathway of ICL repair in cells undergoing active DNA replication (i.e. in S phase), which favours homologous recombination-mediated repair of ICL-induced DSBs in collapsed replication forks [60] . Notably, we have shown that replication forks collapse without WRN function [38] and that restoration of a Holliday-junction nuclease activity can overcome this defect [47] . Hence it is likely that WRN exonuclease may play a role in ICL repair, possibly during the HR step, particularly in highly proliferating cells. We therefore chose to study larval neuroblasts as these represent a proliferative population that is accessible to experimental intervention following dissection of larval neural tissues. We challenged proliferating Drosophila cells derived from both DmWRNexo and DmEXD2 mutant strains with two ICL inducers, diepoxybutane and MMC, since these agents cause different degrees of helical distortion in duplex DNA and may therefore trigger divergent ICL repair pathways. We clearly demonstrate that both EXD2 and WRN exonuclease are required for repair of ICLs (irrespective of mode of induction), since cells lacking either activity fail to remove cross-links, as demonstrated in our inverse comet assay.
We find notable differences in the recovery of larval neuroblasts on exposure to DEB compared with MMC. In particular, DmEXD2 mutants showed low but significant levels of repair following a one hour recovery period after exposure to DEB ( Figure 5C ) but no recovery when exposed to MMC ( Figure 6B ). In the absence of a recovery period, the mutant neurobasts treated with DEB were much worse in terms of repair than untreated controls, while the ICL repair-deficient mus308 D2 homozygous neuroblasts were instead slightly more sensitive to DEB than to MMC.
These differences might be explained (at least in part) by the chemical, structural, and mechanistic differences in the induction of DNA damage by the individual molecules, although the exact mechanism remains to be determined. Both DEB and MMC are bifunctional alkylating agents and form monoadducts and/or abasic sites in addition to ICLs (biadducts), although their cytotoxicity is attributed to ICLs [61] [62] [63] . These perturbations typically result in single-stranded DNA breaks, the rate of formation of which might differ between the two alkylating agents, resulting in the observed differences. Specifically, ICLs produced by DEB result in substantial DNA helix distortion to the magnitude of ~34° per lesion towards the major groove [64] while those produced by MMC are minimal [65] . The extent of helical distortion has been shown to influence the efficiency of nuclease activity near ICLs, with the less-distorting lesions showing a ~3-fold lower incision frequency [66] . This might effectively make MMC-induced ICLs harder to nick, resulting in a more efficient readout of ICL repair deficiency in the mutant genotypes vs the wild type ( Figure 6 ).
Despite these expected drug-dependent differences, the finding that ICL repair is defective in both DmWRNexo e04496 and DmEXD2 c05871 single mutants is highly suggestive that each nuclease is necessary in order to carry out efficient ICL repair. We have therefore, for the first time, demonstrated that both EXD2 and WRN exonucleases are required for efficient repair of ICLs.
Crosslinking agents used in cancer therapy can also drive mutagenesis and yield secondary malignancies. Since crosslinker-induced cytotoxicity and mutagenesis can be altered differently by different DNA repair pathways, it is important to understand all possible mechanisms of ICL
toxicity. An important consideration in therapeutic regimens involving combination therapy is the spectrum of DNA damage induced by specific crosslinking agents, where agents with complementary spectra of DNA damage can derive maximum benefit [67] . ICL-inducing agents may be particularly effective cancer treatment in the presence of FA gene mutations, so in tumours with intact ICL repair genes, an alternative treatment strategy would include a combination of ICL-inducing agents together with inhibitors of ICL repair pathways [68] . Inclusion of inhibitors of WRN and/or EXD2 as possible therapeutic agents to increase the efficacy whilst reducing the required dose of crosslinking agents such as cisplatin might have great potential for developing safer and more efficient treatment strategies for cancer, as ICL-inducers at currently used doses are highly toxic to normal as well as cancer cells leading to serious side-effects [46] .
Our findings also have implications for human ageing processes. Chronic accumulation of DNA damage, both from prolonged exposure to low-level environmental genotoxins and endogenous damage, and from errors in replication, repair and recombination, can trigger a p53-dependent DNA damage response that ultimately result in cellular senescence. Werner patient cells show both increased genomic instability (especially at the telomeres) and accelerated onset of cellular senescence, suggesting that their inability to effectively tackle DNA damage may drive senescence.
While the rate of spontaneous ICL formation is currently unknown, the evolution of pathways for efficient repair suggests that it is not trivial. We suggest that better understanding of ICL repair pathways involving WRN or EXD2 may lead to the discovery of targets and small molecules that may have the potential to alleviate or delay the adverse effects of cell senescence caused by some genotoxic stresses -as accumulation of senescent cells is detrimental to tissue integrity and function [69] [70] [71] [72] [73] , such agents would have potential to alleviate diseases of ageing.
We conclude that both WRN and EXD2 could serve as important targets for treating ageassociated adverse effects including some types of cancers. Combination synthetic lethality therapy should aid development of more efficient treatment strategies with relatively milder side effects due to reduction in doses of harmful non-specific genotoxic chemotherapeutic agents. The threshold line at 0.5 represents the expected homozygote to heterozygote ratio for control treatments (i.e. no DEB in medium). Significant decreases in this ratio imply significant sensitivity of homozygous mutant flies to DEB-induction of ICLs (see Supplemental Table S1 within each genotype were standardized to the H+D-control and statistical significant differences between mutant strains and wild type Oregon-R was calculated using the Mann-Whitney U Wilcoxon W test. *** represents p<0.001 (see Supplementary Table S2 for more details). Error bars represent standard error. Table S3 for more detail). Error bars represent standard error.
